Electra Therapeutics
PublicElectra Therapeutics is now publicly traded
The data on this page reflects Electra Therapeutics's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Series C
Oct 22, 2025
Est. Valuation at Exit
$479M
Total Funding Raised
$267M
Company Overview
Electra Therapeutics is a biotechnology company developing antibody therapies that target signal regulatory proteins to treat immunological diseases and cancer.
Sector
Biotech
Verticals
Life Sciences, Oncology
AI Layer
Non-AI
Keywords
Electra Therapeutics Comparables
Compare Electra Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ALX Oncology | 84% | |
| Biosion, Inc. | 81% | |
| Alector | 78% |
Electra Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Oct 22, 2025 | ||||
| Series B | Feb 16, 2022 |
Electra Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Redmile Group | Series B, Series C |
| RA Capital Management | Series C, Series B |
| New Leaf Venture Partners | Series C, Series B |
| EQT Life Sciences | Series C |
| Westlake Village BioPartners | Series C, Series B |
| Cowen Private Investments | Series B |
| Cormorant Asset Management | Series C, Series B |
Recent news
Latest coverage and updates
- receives_financingSep 18, 2026
Electra Therapeutics Inc. received financing of $350M in IPO on Sep 18th '26.
- is_developingSep 10, 2026
Electra Therapeutics Inc. is developing ELA822 on Sep 10th '26.
- promotesSep 9, 2026
Electra Therapeutics Inc. promoted Chris Clark to Chief Financial Officer on Sep 9th '26.
- hiresSep 9, 2026
Electra Therapeutics Inc. hired Clark as Vice President, Strategy and Finance on Dec 1st '25.
- goes_publicAug 28, 2026
Electra Therapeutics Inc. was planning to go public on Aug 28th '26.
Electra Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access